Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:11 AM
Ignite Modification Date:
2025-12-25 @ 4:11 AM
NCT ID:
NCT01160120
Eligibility Criteria:
Inclusion Criteria:
* Signed informed consent
* Evidence of HIV infection
* Age\> 18 years
* On a TDF/3TC/EFV (separated pills) containing HAART regimen with a VL \< 50 copies within 24 weeks or ARV naïve
* eGFR \>70 cc/min
* Currently having no AIDS defining illness
* No history of NRTI/NNRTI/PI failure
* Willing to adhere to the protocol requirements
Exclusion Criteria:
* Any history of taking CYP450 inhibitors or inducers drugs within 14 days of enrollment in the study
* Current pregnancy or lactating or plan to be pregnant
* Active opportunistic infection
* ALT more than 2 x upper limit
* Creatinine more than 1.5 time the upper limit
* Active drug abuse
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01160120
Study Brief:
Protocol Section:
NCT01160120